Research ArticleResearch Article

Presentation of Axillary Metastases from Occult Breast Carcinoma

Xin Wang
Chinese Journal of Clinical Oncology February 2007, 4 (1) 1-5; DOI: https://doi.org/10.1007/s11805-007-0001-3

REFERENCES

  1. ↵
    1. Halsted W
    . The results of radical operation for the cure of carcinoma of the breast. Ann surg 1907;46:1–19.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Cameron HC
    . Some clinical facts regarding mammary cancer. BMJ 1909;1:577–582.
    OpenUrlFREE Full Text
  3. ↵
    1. Kemeny MM,
    2. Rivera DE,
    3. Terz JJ, et al.
    Occult primary adenocarcinoma with axillary metastases. Am J Surg 1986;152:43–47.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Baron PL,
    2. Moore MP,
    3. Kinne DW, et al.
    Occult breast cancer presenting with axillary metastases: updated management. Arch Surg 1990;125:210–214.
    OpenUrlCrossRefPubMedWeb of Science
    1. Vilcoq JR,
    2. Calle R,
    3. Ferme F, et al.
    Conservative treatment of axillary adenopathy due to probable subclinical breast cancer. Arch Surg 1982;117:1136–1138.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Foroudi F,
    2. Tiver KW
    . Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys 2000;47:143–147.
    OpenUrlPubMed
    1. Fitts WT,
    2. Steiner GC,
    3. Enterline HT
    . Prognosis of occult carcinoma of the breast. Am J Surg 1963; 106:460–463.
    OpenUrl
  8. ↵
    1. Shi S,
    2. Liu L,
    3. Li Y, et al.
    Occult breast cancer (33 cases report). Chin J Clin Oncol 1987;14:155 (Chinese).
    OpenUrl
  9. ↵
    1. Lee WJ,
    2. Chu JS,
    3. Chang KJ, et al.
    Occult breast carcinoma—use of color Doppler in localization. Breast Cancer Res Treat 1996;37:299–302.
    OpenUrlPubMed
  10. ↵
    1. Morris EA,
    2. Schwartz LH,
    3. Dershaw DD, et al.
    MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997;205:437–40.
    OpenUrlPubMed
  11. ↵
    1. Blanchard DK,
    2. Farley DR
    . Retrospective study of women presenting with axillary metastases from occult breast carcinoma. World J Surg 2004;28:535–539.
    OpenUrlPubMed
  12. ↵
    1. Dockerty MB,
    2. Grag HK,
    3. Pierce EH
    . Surgical significance of isolated axillary adenopathy. Ann Surg 1957;145:104–107.
    OpenUrlPubMed
  13. ↵
    1. Singletary SE,
    2. Robb GL,
    3. Hortobagyi GN
    1. Brenin DR
    . The unknown primary tumor presenting with axillary lymphadenopathy. In: Singletary SE, Robb GL, Hortobagyi GN, eds. Advanced Therapy of breast disease. London: BC Decker Inc 2004;659–665.
  14. ↵
    1. Kaufmann O,
    2. Deidesheimer T,
    3. Muehlenberg M, et al.
    Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology 1996;29:233–240.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Niu Y,
    2. Fu XL,
    3. Niu RF, et al.
    Significance of the monoclonal antibody M4G3 against human breast cancer in the diagnosis of the occult breast cancer. Chin J Exp Surg 2003;20:654–656 (Chinese).
    OpenUrl
  16. ↵
    1. Newstead GM
    . MR imaging in the management of patients with breast cancer. Semin Ultrasound CT MR 2006;27:320–332.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Orel SG,
    2. Weinstein SP,
    3. Schnall MD, et al.
    Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999;212:543–549.
    OpenUrlPubMedWeb of Science
  18. ↵
    1. Olson JA,
    2. Morris EA,
    3. Van Zee KJ, et al.
    Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000;7:411–415.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Avril N,
    2. Dose J,
    3. Janicke F, et al.
    Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-flouro-2-deoxy-D-glucose. J Natl Cancer Inst 1996;88:1204–1209.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Danielsson R,
    2. Reihner E,
    3. Grabowska A, et al.
    The role of scintimammography with 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer. Acta Radiol 2000;41:441–445.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Yamaguchi H,
    2. Ishikawa M,
    3. Hatanaka K, et al.
    Occult breast cancer presenting as axillary metastases. Breast 2006;15:259–262.
    OpenUrlPubMed
  22. ↵
    1. Li SL
    . Update of Breast cancer. 1st ed. Jinan: Jinan Publishing House 1996 (Chinese).
  23. ↵
    1. Vlastos G,
    2. Jean M,
    3. Mirza AN, et al.
    Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 2001;8:425–431.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Feigenberg Z,
    2. Zer M,
    3. Dintsman M
    . Axillary metastases from an unknown primary source. Isr J Med Sci. 1976;12:1153–1158.
    OpenUrlPubMed
  25. ↵
    1. Bland KI,
    2. Copeland EM, III.
    1. Tench DW,
    2. Page DL
    . The unknown primary presenting with axillary lymphadenopathy. In: Bland KI, Copeland EM, III. eds. The Breast: Comprehensive Management of Benign and Malignant Disease. London: Saunders 1991:1041–1045.
  26. ↵
    1. Merson M,
    2. Andreola S,
    3. Galmiberti V, et al.
    Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer 1992;70:504–508.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. van Ooijen B,
    2. Bontenbal M,
    3. Henzen-Logmans SC, et al.
    Axillary nodal metastases from an occult primary consistent with breast carcinoma. Br J Surg 1993;80:1299–1300.
    OpenUrlPubMed
  28. ↵
    1. Medina-Franco H,
    2. Urist MM
    . Occult breast carcinoma presenting with axillary lymph node metastases. Rev Invest Clin 2002;54:204–208.
    OpenUrlPubMed
  29. ↵
    1. Khandelwal AK,
    2. Garguilo GA
    . Therapeutic options for occult breast cancer: a survey of the American Society of Breast Surgeons and review of the literature. Am J Surg 2005;190:609–613.
    OpenUrlPubMed
  30. ↵
    1. Feuerman L,
    2. Attie JN,
    3. Rosenberg B
    . Carcinoma in axillary lymph nodes as an indicator of breast cancer. Surg Gynecol Obstet 1962;114:5–8.
    OpenUrlPubMed
  31. ↵
    1. Campana F,
    2. Fourquet A,
    3. Ashby MA, et al.
    Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie. Radiother Oncol 1989; 15:321–325.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Rosen PP,
    2. Kimmel M
    . Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol 1990;21:518–523.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Patel J,
    2. Takuma N,
    3. Dutau R, et al.
    Axillary lymph node metastasis from an occult breast cancer. Cancer 1981;47:2923–2927.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords